Tesaro New Drug Provides Real Benefit To Ovarian Cancer Patients

0
Patients with platinum-sensitive recurrent ovarian cancer showed significantly improved cancer-free survival with Tesaro (niraparib) in the first clinical trial directly comparing a poly(ADP)-ribose polymerase (PARP) inhibitor with chemotherapy.Tesaro improved cancer-free survival...